Cresilon, Inc. Stock
Cresilon is a medical device company that produces and markets solutions for trauma care.
Sign up today and learn more about Cresilon, Inc. Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Cresilon, Inc. Stock
Cresilon is a medical device company that produces and markets solutions for trauma care. The company’s proprietary product, VETIGEL(TM), is a hemostatic gel made from plant-derived materials to stop traumatic bleeding in seconds. It functions as a blood-clotting agent, and also as a scaffold to facilitate skin growth. Cresilon was co-founded by Joe Landolina and Isaac Miller in 2010 and is based in New York, United States.
Funding History
| May 2013 | $0 |
|---|---|
| May 2015 | $0 |
| January 2016 | $0 |
| December 2017 | $0 |
Management
CFO, Co-Founder
Isaac Miller
CEO, Co-Founder
Joe Landolina
Press
observer - Jun, 25 2015
Gel That Rapidly Stops Bleeding to Enter Veterinary MarketEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
